Novo Nordisk A/S ADR sell Akuma
Start price
05.02.26
/
0%
€36.95
Target price
05.02.27
-
Performance (%)
-15.16%
End price
03.03.26
€31.35
Summary
This prediction ended on 03.03.26 with a price of €31.35. The prediction for Novo Nordisk A/S ADR closed with a convincing performance of -15.16%. Akuma has a follow-up prediction for Novo Nordisk A/S ADR, but this time predicts that Novo Nordisk A/S ADR is a Buy. This prediction was marked as speculative and is excluded from Akuma's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 6.676% | 6.676% |
| iShares Core DAX® | 1,01 % | 2,70 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % |
| iShares S&P 500 | -2,72 % | -1,75 % |
Comments by Akuma for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Sell Novo Nordisk A/S ADR